The COVID-19 vaccine development multiverse

New England Journal of Medicine

14 July 2020 - Leaving in its wake more than 12 million infections, over 550,000 deaths, and an economic toll in the trillions of dollars to date, the SARS-CoV-2 pandemic has devastated the most vulnerable in our society — adults 65 years of age or older, persons with underlying conditions, and the economically deprived. 

A vaccine is urgently needed to prevent COVID-19 and thereby stem complications and deaths resulting from transmission of the disease.

Read New England Journal of Medicine article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Vaccine , Drug development , COVID-19